Status:
COMPLETED
A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide)
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Lung Cancer
Eligibility:
All Genders
40+ years
Phase:
PHASE2
PHASE3
Brief Summary
Studies in animals suggest that inhaled budesonide may prevent the occurrence of lung cancer. We conducted a clinical trial to determine the effects of inhaled budesonide in smokers who had precancero...
Detailed Description
Lung cancer is the most common cause of cancer death worldwide: the mortality rate of lung cancer exceeds that of colon, breast, and prostate cancers combined. Former heavy smokers retain an elevated ...
Eligibility Criteria
Inclusion
- age \> 40 years; smoking history of 30 pack-years or more; normal organ function; sputum atypia
Exclusion
- general debility that would prevent completion of 6 month follow-up; existing cancer diagnosis
Key Trial Info
Start Date :
January 1 2000
Trial Type :
INTERVENTIONAL
End Date :
December 1 2002
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00175747
Start Date
January 1 2000
End Date
December 1 2002
Last Update
September 15 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
British Columbia Cancer Agency
Vancouver, British Columbia, Canada, V5Z 4E6